{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:37:11Z","timestamp":1792100231864,"version":"4.4.0"},"reference-count":76,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>The positive effects of growth hormone (GH) on IVF are often attributed to improvements in oocyte and embryo quality. While emerging evidence emphasizes GH-induced improvements in the endometrium, these results are controversial.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OBJECTIVE AND RATIONALE<\/jats:title>\n                  <jats:p>This meta-analysis aimed to evaluate whether GH administration improved endometrial function and reproductive outcomes during IVF cycles and to thus guide clinical practice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SEARCH METHODS<\/jats:title>\n                  <jats:p>A literature search in the Cochrane Central Register of Controlled Trials, PubMed and Embase was performed through to 30 November 2021, without language restrictions. Randomized controlled trials (RCTs) evaluating the effects of GH on IVF outcomes were included. Risk of bias and quality of evidence (QoE) were assessed according to the Cochrane Collaboration\u2019s tool and the Grading of Recommendations Assessment, Development and Evaluation system. Odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals (CIs) were assessed by random-effects models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>OUTCOMES<\/jats:title>\n                  <jats:p>A total of 25 trials with 2424 women were included. Seventeen RCTs with poor responders (n\u2009=\u20091723) showed that GH administration significantly increased endometrial thickness (EMT) (MD\u2009=\u20090.38, 95% CI: 0.18\u20130.59; moderate QoE), which contributed to an improved live birth rate (OR\u2009=\u20091.67, 95% CI: 1.13\u20132.49; very low QoE) and clinical pregnancy rate (CPR) (OR\u2009=\u20091.97, 95% CI: 1.43\u20132.72; low QoE). Subgroup analyses showed a dose- and time-dependent relationship between GH cotreatment and IVF outcomes; the optimal recommendation for improving CPR was consistent with that for EMT, rather than for oocytes and embryos. Hence, GH might improve fertility via effects on the endometrium. Administration of GH daily from the follicular phase of previous cycle until the hCG trigger with &amp;lt; 5\u2009IU\/day led to a thicker endometrium and a greater chance of becoming pregnant, while 5\u201310\u2009IU\/day or administration from the luteal phase of the previous cycle until the hCG trigger resulted in higher oocyte and embryo quality. Poor responders might benefit from cotreatment with the GnRH agonist long protocol more than other stimulation protocols. Pooled data from four trials (n\u2009=\u2009354) on women with a thin endometrium indicated that improved endometrial function might be critical for improving reproductive outcomes during GH treatment, as no improvements in embryo quality were found. GH administration not only increased EMT (MD\u2009=\u20091.48, 95% CI: 1.21\u20131.75; moderate QoE) but also promoted endometrial morphology (OR\u2009=\u20092.67, 95% CI: 1.36\u20135.23; low QoE) and perfusion (OR\u2009=\u20095.84, 95% CI: 1.30\u201326.17; low QoE), thereby improving the CPR (OR\u2009=\u20092.71, 95% CI: 1.69\u20134.34; P\u2009&amp;lt;\u20090.0001; low QoE). There was insufficient evidence to reach a conclusion regarding the effects of GH in normal responders (n\u2009=\u200980). Due to obvious improvements in the CPR, women with a thin endometrium might be the most appropriate population to benefit from GH administration.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS<\/jats:title>\n                  <jats:p>Improving endometrial function might be another vital mechanism by which GH improves IVF outcomes. Optimal treatment should be offered to the target population according to their personal conditions and needs. The QoE was moderate to very low, due to limited sample sizes and methodological problems; thus, the results should be interpreted with caution. More rigorous RCTs with large sample sizes are needed to confirm the effects and determine optimal GH protocols.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/humupd\/dmac028","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:55:12Z","timestamp":1654044912000},"page":"838-857","source":"Crossref","is-referenced-by-count":32,"title":["Administration of growth hormone improves endometrial function in women undergoing <i>in vitro<\/i> fertilization: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2900-7575","authenticated-orcid":false,"given":"Yujie","family":"Shang","sequence":"first","affiliation":[{"name":"Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University , Changsha, China"},{"name":"The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University , Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghua","family":"Wu","sequence":"additional","affiliation":[{"name":"Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University , Changsha, China"},{"name":"The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University , Changsha, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohan","family":"He","sequence":"additional","affiliation":[{"name":"Integrated TCM & Western Medicine Department, Maternal and Child Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Gynaecology, Cangzhou Hospital of Integrated TCM-WM , Cangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Sun","sequence":"additional","affiliation":[{"name":"Second Affiliated Hospital of Xuzhou Medical University , Xuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,5,31]]},"reference":[{"key":"2022110214281160600_dmac028-B1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/js.2017-00359","article-title":"Effect of growth hormone on uterine receptivity in women with repeated implantation failure in an oocyte donation program: a randomized controlled trial","volume":"2","author":"Altm\u00e4e","year":"2018","journal-title":"J Endocr Soc"},{"key":"2022110214281160600_dmac028-B2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1469-0705.1995.05010067.x","article-title":"The uterine biophysical profile","volume":"5","author":"Applebaum","year":"1995","journal-title":"Ultrasound Obstet Gynecol"},{"key":"2022110214281160600_dmac028-B3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.fertnstert.2015.11.026","article-title":"Does the addition of growth hormone to the in vitro fertilization\/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial","volume":"105","author":"Bassiouny","year":"2016","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijgo.2015.05.034","article-title":"Addition of growth hormone to the microflare stimulation protocol among women with poor ovarian response","volume":"131","author":"Bayoumi","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"2022110214281160600_dmac028-B5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0015-0282(16)56825-3","article-title":"Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study","volume":"62","author":"Bergh","year":"1994","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B6","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2147\/DDDT.S201871","article-title":"Comparative proteomics reveal negative effects of gonadotropin-releasing hormone agonist and antagonist on human endometrium","volume":"13","author":"Chen","year":"2019","journal-title":"Drug Des Devel Ther"},{"key":"2022110214281160600_dmac028-B7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1139\/cjpp-2017-0786","article-title":"Clinical efficacy and mechanism of growth hormone action in patients experiencing repeat implantation failure","volume":"96","author":"Chen","year":"2018","journal-title":"Can J Physiol Pharmacol"},{"key":"2022110214281160600_dmac028-B8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00404-017-4613-4","article-title":"Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study","volume":"297","author":"Choe","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"2022110214281160600_dmac028-B9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.fertnstert.2020.03.007","article-title":"Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis","volume":"114","author":"Cozzolino","year":"2020","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/humupd\/dmy044","article-title":"Conventional and modern markers of endometrial receptivity: a systematic review and meta-analysis","volume":"25","author":"Craciunas","year":"2019","journal-title":"Hum Reprod Update"},{"key":"2022110214281160600_dmac028-B11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40618-018-0877-1","article-title":"Effects of growth hormone on pregnancy rates of patients with thin endometrium","volume":"42","author":"Cui","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"2022110214281160600_dmac028-B12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ejogrb.2018.06.035","article-title":"The addition of growth hormone adjuvant therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: randomized control trial","volume":"228","author":"Dakhly","year":"2018","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2022110214281160600_dmac028-B13","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3109\/09513590.2015.1092136","article-title":"Which is the best IVF\/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial","volume":"32","author":"Dakhly","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"2022110214281160600_dmac028-B14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/humupd\/dmaa035","article-title":"Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis","volume":"27","author":"Datta","year":"2021","journal-title":"Hum Reprod Update"},{"key":"2022110214281160600_dmac028-B15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/humrep\/10.1.40","article-title":"Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study","volume":"10","author":"Dor","year":"1995","journal-title":"Hum Reprod"},{"key":"2022110214281160600_dmac028-B16","first-page":"CD000099","article-title":"Growth hormone for in vitro fertilization","volume":"2010","author":"Duffy","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2022110214281160600_dmac028-B17","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00404-012-2655-1","article-title":"Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology","volume":"287","author":"Eftekhar","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"2022110214281160600_dmac028-B18","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.fertnstert.2007.04.031","article-title":"The relationship between endometrial thickness and outcome of medicated frozen embryo replacement cycles","volume":"89","author":"El-Toukhy","year":"2008","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B19","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF01135678","article-title":"Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF)","volume":"7","author":"Gonen","year":"1990","journal-title":"J in Vitro Fert Embryo Transf"},{"key":"2022110214281160600_dmac028-B20","doi-asserted-by":"crossref","first-page":"18769","DOI":"10.1038\/s41598-020-75107-4","article-title":"Growth hormone alleviates oxidative stress and improves oocyte quality in Chinese women with polycystic ovary syndrome: a randomized controlled trial","volume":"10","author":"Gong","year":"2020","journal-title":"Sci Rep"},{"key":"2022110214281160600_dmac028-B21","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12958-020-00648-2","article-title":"Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial","volume":"18","author":"Gong","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"2022110214281160600_dmac028-B22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"2022110214281160600_dmac028-B23","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1210\/en.2011-1248","article-title":"Analysis of fertility-related soluble mediators in human uterine fluid identifies VEGF as a key regulator of embryo implantation","volume":"152","author":"Hannan","year":"2011","journal-title":"Endocrinology"},{"key":"2022110214281160600_dmac028-B24","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/GCO.0000000000000360","article-title":"Growth hormone in IVF cycles: any hope?","volume":"29","author":"Hart","year":"2017","journal-title":"Curr Opin Obstet Gynecol"},{"key":"2022110214281160600_dmac028-B25","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S1472-6483(10)60011-9","article-title":"Effect of growth hormone on oocyte competence in patients with multiple IVF failures","volume":"18","author":"Hazout","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"2022110214281160600_dmac028-B78","article-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022)","author":"Higgins","year":"2022","journal-title":"Cochrane"},{"key":"2022110214281160600_dmac028-B26","first-page":"914","article-title":"Effect of growth hormone on the endometrium and endometrial blood flow in frozen-thawed embryo transfer","volume":"22","author":"Hongbo","year":"2013","journal-title":"J Reprod Med"},{"key":"2022110214281160600_dmac028-B27","first-page":"530","article-title":"A clinical study of recombinant human growth hormone to improve the endometrial receptivity in frozen embryo transfer cycles","volume":"27","author":"Huang","year":"2011","journal-title":"Chinese J Pract Gynecol Obstet"},{"key":"2022110214281160600_dmac028-B29","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/humrep\/der128","article-title":"Integrin \u03b23 in rat blastocysts and epithelial cells is essential for implantation in vitro: studies with Ishikawa cells and small interfering RNA transfection","volume":"26","author":"Kaneko","year":"2011","journal-title":"Hum Reprod"},{"key":"2022110214281160600_dmac028-B30","doi-asserted-by":"crossref","first-page":"4141","DOI":"10.1002\/jcb.26088","article-title":"Implantation window and angiogenesis","volume":"118","author":"Karizbodagh","year":"2017","journal-title":"J Cell Biochem"},{"key":"2022110214281160600_dmac028-B31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10815-008-9212-7","article-title":"Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial","volume":"25","author":"Kucuk","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"2022110214281160600_dmac028-B32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk","year":"2017","journal-title":"Hum Reprod Update"},{"key":"2022110214281160600_dmac028-B33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fendo.2019.00892","article-title":"Low dose growth hormone adjuvant treatment with ultra-long ovarian stimulation protocol in poor responders showed non-inferior pregnancy outcome compared with normal responders","volume":"10","author":"Lee","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022110214281160600_dmac028-B34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12884-020-03004-9","article-title":"Does growth hormone supplementation improve oocyte competence and IVF outcomes in patients with poor embryonic development? A randomized controlled trial","volume":"20","author":"Li","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"2022110214281160600_dmac028-B35","first-page":"3957","article-title":"Application of growth hormone in artificial FET cycle of patients with maldevelopment of endometrium","volume":"30","author":"Li","year":"2015","journal-title":"Matern Child Heal Care China"},{"key":"2022110214281160600_dmac028-B36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/ijgo.13933","article-title":"Efficacy of the depot gonadotropin-releasing hormone agonist protocol on in vitro fertilization outcomes in young poor ovarian responders from POSEIDON group 3","volume":"157","author":"Li","year":"2022","journal-title":"Int J Gynecol Obstet"},{"key":"2022110214281160600_dmac028-B37","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s43032-020-00298-0","article-title":"Effects of growth hormone supplementation on poor ovarian responders in assisted reproductive technology: a systematic review and meta-analysis","volume":"28","author":"Liu","year":"2021","journal-title":"Reprod Sci"},{"key":"2022110214281160600_dmac028-B38","first-page":"560","article-title":"A meta-analysis of the efficacy of growth hormone in patients with endometrial dysplasia duringin vitro fertilization and embryo transplantation","author":"Liu","year":"2014","journal-title":"Prog Obs Gynecol"},{"key":"2022110214281160600_dmac028-B39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1210\/er.2005-0015","article-title":"The science behind 25 years of ovarian stimulation for in vitro fertilization","volume":"27","author":"Macklon","year":"2006","journal-title":"Endocr Rev"},{"key":"2022110214281160600_dmac028-B40","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1186\/s12884-020-03372-2","article-title":"Continuous endometrial volumetric analysis for endometrial receptivity assessment on assisted reproductive technology cycles","volume":"20","author":"Martins","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"2022110214281160600_dmac028-B41","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tjog.2020.10.003","article-title":"Efficacy of growth hormone supplementation with ultrashort GnRH antagonist in IVF\/ICSI for poor responders: randomized controlled trial","volume":"60","author":"Mohammad","year":"2021","journal-title":"Taiwan J Obstet Gynecol"},{"key":"2022110214281160600_dmac028-B42","first-page":"148","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"20","author":"Moher","year":"2016","journal-title":"Rev Esp Nutr Humana y Diet"},{"key":"2022110214281160600_dmac028-B43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0140-6736(91)90427-Q","article-title":"High fecundity of amenorrhoeic women in embryo-transfer programmes","volume":"338","author":"Morcos","year":"1991","journal-title":"Lancet"},{"key":"2022110214281160600_dmac028-B44","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.rbmo.2019.02.003","article-title":"Human growth hormone for poor responders: a randomized placebo-controlled trial provides no evidence for improved live birth rate","volume":"38","author":"Norman","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"2022110214281160600_dmac028-B45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/humupd\/dmaa054","article-title":"Embryo implantation in the laboratory: an update on current techniques","volume":"27","author":"Ojosnegros","year":"2021","journal-title":"Hum Reprod Update"},{"key":"2022110214281160600_dmac028-B46","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0015-0282(16)54724-4","article-title":"Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo- control trial","volume":"56","author":"Owen","year":"1991","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B47","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Oxman","year":"2004","journal-title":"Br Med J"},{"key":"2022110214281160600_dmac028-B48","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1210\/en.2008-0286","article-title":"Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells","volume":"149","author":"Pandey","year":"2008","journal-title":"Endocrinology"},{"key":"2022110214281160600_dmac028-B49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.fertnstert.2020.07.002","article-title":"Rate of true recurrent implantation failure is low: results of three successive frozen euploid single embryo transfers","volume":"115","author":"Pirtea","year":"2021","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B50","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.fertnstert.2018.08.018","article-title":"Growth hormone during in vitro fertilization in older women modulates the density of receptors in granulosa cells, with improved pregnancy outcomes","volume":"110","author":"Regan","year":"2018","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B51","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.fertnstert.2014.03.030","article-title":"Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?","volume":"102","author":"Ren","year":"2014","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.fertnstert.2006.05.064","article-title":"Relationship between endometrial thickness and embryo implantation, based on 1,294 cycles of in vitro fertilization with transfer of two blastocyst-stage embryos","volume":"87","author":"Richter","year":"2007","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B54","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.31557\/APJCP.2019.20.7.2033","article-title":"Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study","volume":"20","author":"Safdarian","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"key":"2022110214281160600_dmac028-B55","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1046\/j.8755-8920.2003.00127.x","article-title":"Immunohistochemical localization of the growth hormone in human endometrium and decidua","volume":"51","author":"Sbracia","year":"2004","journal-title":"Am J Reprod Immunol"},{"key":"2022110214281160600_dmac028-B56","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1749-6632.1991.tb37925.x","article-title":"Influence of growth factors EGF, IGF-1, and human growth hormone on human endometrial stromal cells in vitro","volume":"626","author":"Strowitzki","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"2022110214281160600_dmac028-B57","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0015-0282(16)58217-X","article-title":"Double-blind placebo controlled study: human biosynthetic growth hormone for assisted reproductive technology","volume":"65","author":"Suikkari","year":"1996","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B58","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10815-007-9164-3","article-title":"The incidence of aberrant endometrial \u03b1v\u03b23 vitronectin expression in a high risk infertility population: could prolonged GnRH agonist therapy play a role?","volume":"24","author":"Surrey","year":"2007","journal-title":"J Assist Reprod Genet"},{"key":"2022110214281160600_dmac028-B59","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0015-0282(16)55319-9","article-title":"Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells","volume":"58","author":"Tapanainen","year":"1992","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B60","doi-asserted-by":"crossref","first-page":"519572","DOI":"10.3389\/fendo.2020.519572","article-title":"The effect of GH administration on oocyte and zygote quality in young women with repeated implantation failure after IVF","volume":"11","author":"Tesarik","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022110214281160600_dmac028-B61","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1093\/humrep\/dei066","article-title":"Improvement of delivery and live birth rates after ICSI in women aged &gt;40 years by ovarian co-stimulation with growth hormone","volume":"20","author":"Tesarik","year":"2005","journal-title":"Hum Reprod"},{"key":"2022110214281160600_dmac028-B62","doi-asserted-by":"crossref","first-page":"944","DOI":"10.21037\/atm-20-5463","article-title":"Analysis of the guidance value of 3D ultrasound in evaluating endometrial receptivity for frozen-thawed embryo transfer in patients with repeated implantation failure","volume":"8","author":"Tong","year":"2020","journal-title":"Ann Transl Med"},{"key":"2022110214281160600_dmac028-B63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1387\/ijdb.130345wh","article-title":"Molecular determinants of uterine receptivity","volume":"58","author":"Tu","year":"2014","journal-title":"Int J Dev Biol"},{"key":"2022110214281160600_dmac028-B64","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.fertnstert.2005.09.028","article-title":"Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and infertility","volume":"85","author":"Wang","year":"2006","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B65","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJM199906103402304","article-title":"Time of implantation of the conceptus and loss of pregnancy","volume":"340","author":"Wilcox","year":"1999","journal-title":"N Engl J Med"},{"key":"2022110214281160600_dmac028-B66","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1477-7827-12-96","article-title":"Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration","volume":"12","author":"Wu","year":"2014","journal-title":"Reprod Biol Endocrinol"},{"key":"2022110214281160600_dmac028-B67","first-page":"56","article-title":"Effect of growth hormone on endometrial receptivity and clinical outcme in IVF patients of maldevelopment endometrium","volume":"32","author":"Xiang","year":"2011","journal-title":"J Med Forum"},{"key":"2022110214281160600_dmac028-B68","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fendo.2019.00502","article-title":"Application of growth hormone in in vitro fertilization","volume":"10","author":"Xu","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2022110214281160600_dmac028-B69","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12958-021-00814-0","article-title":"Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from China","volume":"19","author":"Yang","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"2022110214281160600_dmac028-B70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12958-020-00632-w","article-title":"The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials","volume":"18","author":"Yang","year":"2020","journal-title":"Reprod Biol Endocrinol"},{"key":"2022110214281160600_dmac028-B71","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0015-0282(16)55266-2","article-title":"The effect of growth hormone supplementation on in vitro fertilization outcome: a prospective randomized placebo-controlled double-blind study","volume":"58","author":"Younis","year":"1992","journal-title":"Fertil Steril"},{"key":"2022110214281160600_dmac028-B72","first-page":"11982","article-title":"Growth hormone intrauterine perfusion combined with replacement cycle in the treatment of non-response thin endometrium: report of 5 cases","volume":"9","author":"Yu","year":"2016","journal-title":"Int J Clin Exp Med"},{"key":"2022110214281160600_dmac028-B73","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.rbmo.2016.05.002","article-title":"Endometrial thickness as a predictor of pregnancy outcomes in 10787 fresh IVF-ICSI cycles","volume":"33","author":"Yuan","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"2022110214281160600_dmac028-B74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/humupd\/dmz046","article-title":"Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis","volume":"26","author":"Zhang","year":"2020","journal-title":"Hum Reprod Update"},{"key":"2022110214281160600_dmac028-B75","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1477-7827-10-100","article-title":"The effect of endometrial thickness and pattern measured by ultrasonography on pregnancy outcomes during IVF-ET cycles","volume":"10","author":"Zhao","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"2022110214281160600_dmac028-B76","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.rbmo.2014.05.011","article-title":"Endometrial pattern, thickness and growth in predicting pregnancy outcome following 3319 IVF cycle","volume":"29","author":"Zhao","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"2022110214281160600_dmac028-B77","first-page":"471","article-title":"The effect of co-administration of low dosage growth hormone and gonadotropin for ovarian hyperstimulation in vitro fertilization and embryo transfer","volume":"29","author":"Zhuang","year":"1994","journal-title":"Chinese J Obstet Gynaecol"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/humupd\/article-pdf\/28\/6\/838\/46749649\/dmac028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/humupd\/article-pdf\/28\/6\/838\/46749649\/dmac028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T15:58:38Z","timestamp":1667404718000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/28\/6\/838\/6596135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":76,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,5,31]]},"published-print":{"date-parts":[[2022,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmac028","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,5,31]]}}}